Response to the article by Lai et al. "Comment on Ormaza Vera et al. 'Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic naıve patients with psoriasis: A retrospective cohort study''' Letter

publication date

  • August 1, 2025

webpage

published in

keywords

  • MACEs
  • biologics
  • cardiovascular risk
  • diabetes
  • dyslipidemia
  • hypertension
  • psoriasis
  • psoriasis therapy

start page

  • e53

end page

  • e54

volume

  • 93

issue

  • 2